Gajewski TF - Search Results

1

The STING pathway and the T cell-inflamed tumor microenvironment.

Woo SR, Corrales L, Gajewski TF. Woo SR, et al. Among authors: gajewski tf. Trends Immunol. 2015 Apr;36(4):250-6. doi: 10.1016/j.it.2015.02.003. Epub 2015 Mar 7. Trends Immunol. 2015. PMID: 25758021 Free PMC article. Review.

2

Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.

Fallarino F, Ashikari A, Boon T, Gajewski TF. Fallarino F, et al. Among authors: gajewski tf. Int Immunol. 1997 Sep;9(9):1259-69. doi: 10.1093/intimm/9.9.1259. Int Immunol. 1997. PMID: 9310829

3

The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response.

Markiewicz MA, Gajewski TF. Markiewicz MA, et al. Among authors: gajewski tf. Crit Rev Oncog. 1999;10(3):247-60. Crit Rev Oncog. 1999. PMID: 10468184 Review.

4

Negative regulation of T-cell function by PD-1.

Zha Yy, Blank C, Gajewski TF. Zha Yy, et al. Among authors: gajewski tf. Crit Rev Immunol. 2004;24(4):229-37. doi: 10.1615/critrevimmunol.v24.i4.10. Crit Rev Immunol. 2004. PMID: 15588223 Review.

5

ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo.

Blank C, Brown I, Kacha AK, Markiewicz MA, Gajewski TF. Blank C, et al. Among authors: gajewski tf. J Immunol. 2005 Mar 15;174(6):3416-20. doi: 10.4049/jimmunol.174.6.3416. J Immunol. 2005. PMID: 15749875

6

Metabolic mechanisms of tumor resistance to T cell effector function.

Cham CM, Gajewski TF. Cham CM, et al. Among authors: gajewski tf. Immunol Res. 2005;31(2):107-18. doi: 10.1385/IR:31:2:107. Immunol Res. 2005. PMID: 15778509 Review.

7

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.

Harlin H, Kuna TV, Peterson AC, Meng Y, Gajewski TF. Harlin H, et al. Among authors: gajewski tf. Cancer Immunol Immunother. 2006 Oct;55(10):1185-97. doi: 10.1007/s00262-005-0118-2. Epub 2006 Feb 9. Cancer Immunol Immunother. 2006. PMID: 16468035

8

Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment.

Gajewski TF. Gajewski TF. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2326s-2330s. doi: 10.1158/1078-0432.CCR-05-2517. Clin Cancer Res. 2006. PMID: 16609053 Review.

9

Immune suppression in the tumor microenvironment.

Gajewski TF, Meng Y, Harlin H. Gajewski TF, et al. J Immunother. 2006 May-Jun;29(3):233-40. doi: 10.1097/01.cji.0000199193.29048.56. J Immunother. 2006. PMID: 16699366 Review.

10

Immune resistance orchestrated by the tumor microenvironment.

Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. Gajewski TF, et al. Immunol Rev. 2006 Oct;213:131-45. doi: 10.1111/j.1600-065X.2006.00442.x. Immunol Rev. 2006. PMID: 16972901 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page